| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 264.59B | 278.09B | 260.82B | 192.91B | 202.99B | 184.00B |
| Gross Profit | 26.45B | 25.21B | 27.49B | 23.45B | 20.04B | 17.75B |
| EBITDA | 8.13B | 4.85B | 15.00B | 6.87B | 4.64B | 4.71B |
| Net Income | 1.51B | 2.02B | 9.82B | 1.65B | 1.62B | 814.00M |
Balance Sheet | ||||||
| Total Assets | 252.57B | 286.60B | 286.00B | 256.31B | 240.85B | 218.25B |
| Cash, Cash Equivalents and Short-Term Investments | 79.55B | 90.32B | 119.86B | 108.52B | 92.15B | 97.61B |
| Total Debt | 51.14B | 51.91B | 36.28B | 36.59B | 36.68B | 28.17B |
| Total Liabilities | 195.01B | 226.35B | 221.84B | 207.20B | 196.29B | 178.18B |
| Stockholders Equity | 57.35B | 60.01B | 63.94B | 48.92B | 44.39B | 39.94B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -27.18B | 4.63B | 14.64B | -7.56B | 17.36B |
| Operating Cash Flow | 0.00 | -23.09B | 6.00B | 15.59B | -6.79B | 17.75B |
| Investing Cash Flow | 0.00 | -19.77B | 7.34B | -9.47B | -7.85B | -2.71B |
| Financing Cash Flow | 0.00 | 674.00M | -1.06B | -1.57B | 7.61B | -451.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥269.76B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
75 Outperform | ¥314.39B | 0.79 | 164.12% | ― | -12.14% | ― | |
72 Outperform | ¥1.30T | 12.95 | 14.94% | 2.00% | 16.43% | 53.76% | |
72 Outperform | ¥688.05B | 12.93 | ― | 2.15% | -5.20% | -1.20% | |
65 Neutral | ¥665.83B | 6.30 | -0.24% | 2.10% | -0.41% | 80.25% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
55 Neutral | ¥135.42B | -3.11 | -33.76% | 0.96% | -5.80% | -126.63% |